"The board has decided to acquire 100 percent of the equity stake in Hyacinths Pharma, a company incorporated to manufacture active pharmaceutical ingredients (APIs) from the existing shareholders," the company said in a filing to BSE.
The company's board which met on Thursday also approved the to acquire 25 percent stake in Silicon Life Sciences from the existing shareholder, ABS Mercantiles Pvt Ltd, it added.
"Post this acquisition, the equity holding of the company would increase to 100 percent, thereby making Silicon a wholly owned subsidiary of the company," it said.
The acquisition will help the company consolidate its operations, Aurobindo Pharma said.
The company, however, did not disclose financial details.
The Hyderabad-based firm's board also approved the transfer of injectables business to its wholly-owned subsidiary Curepro Parenterals pursuant to a scheme of arrangement, it added.
Shares of Aurobindo Pharma on Thursday closed at Rs 182.75 on the BSE, down 2.19 percent from its previous close.
Anda sedang membaca artikel tentang
Aurobindo board approves acquisition of Hyacinths Pharma
Dengan url
http://sehatkafein.blogspot.com/2013/09/aurobindo-board-approves-acquisition-of.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Aurobindo board approves acquisition of Hyacinths Pharma
namun jangan lupa untuk meletakkan link
Aurobindo board approves acquisition of Hyacinths Pharma
sebagai sumbernya
0 komentar:
Posting Komentar